Portfolio Changes

Sale of 150 shares of Dynatrace (remaining position); Purchase of 30 shares of Datadog; Purchase of 150 shares of Nutanix. Dynatrace: We eliminated the last of our Dynatrace (DT) position this morning. We were sorry to have to eliminate the position, but at this point the growth divergence between Dynatrace and Datadog was just too great to…

To access this post, you must subscribe.

Read More

Sales of 1500 shares of UiPath and Sale of 150 shares of Dynatrace: Purchase of 300 shares of Nutanix, Purchase of 200 shares of GitLab As we had indicated, we have now eliminated UiPath from the portfolio. Its latest earnings report and guidance were very disappointing, and while the narrative may play out, we simply…

To access this post, you must subscribe.

Read More

The divergence between Crowdstrike and Zscaler (and most everything else). The misunderstood quarter of GitLab; Pagaya raises EBITDA guidance-hopefully construed positively. 1. Crowdstrike Pattern recognition is supposed to be the mainstay of analysis. Most of the time, when I attempt to write an article about a company, or an event, I try to compare it…

To access this post, you must subscribe.

Read More

Summary Shopify shares have experienced significant volatility, with a recent implosion in share price following a disappointing earnings report. Despite this, Shopify has consistently adapted to changing ecommerce environments and has become the largest competitor in its space. The company’s ability to add new merchants at an accelerated pace and its focus on providing a…

To access this post, you must subscribe.

Read More

Sale of 100 Dynatrace and purchase of 200 shares of Confluent The market continues in a risk off pattern this Monday morning. Many stocks are still reacting to the perceived read-through from the results of MongoDB. As I tried to suggest, Mongo’s issues are grossly exaggerated, and really are not representative of what is actually…

To access this post, you must subscribe.

Read More

Portfolio change

Change to the Income/Stability portfolio: Sale of 95 shares of IBM and Purchases of 70 shares of Salesforce As discussed; we have eliminated our holding of IBM shares. We sold the position this morning at a price of $166.54. The sale eliminates the 95 shares of IBM (IBM) we previously held and raised $15,795. We…

To access this post, you must subscribe.

Read More

Portfolio Change

Sale of remaining position in Crowdstrike; Purchase of additional shares of SentinelOne Shares of SentinelOne are under extraordinary pressure this morning. A minor guidedown in revenue of less than 0.5% has led to an extraordinary valuation implosion. I usually wait these things out, but a limit order I had was filled. After yesterday’s precipitous fall,…

To access this post, you must subscribe.

Read More

This has not been the easiest of weeks to be an investor in tech stocks. Sentiment, as I have mentioned, is woeful, and analysts are looking under every bush and rock for negatives. Technical analysis that I have seen, is decidedly negative which is, of course, the outcome of negative sentiment. The cyber security software…

To access this post, you must subscribe.

Read More

UiPath; Nutanix, Pure and Salesforce It’s Thursday, the trading week is half over and there are some notable casualties. UiPath is trading down by about 34% and Salesforce is down by more than 18%. NTNX, which had been “bulled-up” into the numbers, is trading in line with a “sell the news paradigm” and is down…

To access this post, you must subscribe.

Read More

Sale of 100 shares of Crowdstrike at the opening; Sale of 100 shares of DT at the opening; Purchase of 120 shares of CyberArk at the opening, Purchase of 40 shares of Datadog; Comments on the ZS downgrades As we discussed in the portfolio commentary we published yesterday, we are exiting our Crowdstrike position. The…

To access this post, you must subscribe.

Read More